Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jul 1, 2014

In Genetic Haystacks, We’re All Needles

According to Sharon Terry, as we scrutinize diseases at an ever more granular level, we will find that whatever disease a person has, it’s highly likely to be a “rare” disease.

In Genetic Haystacks, We’re All Needles

Sharon Terry is president and CEO of Genetic Alliance.

  • The task of finding and recruiting sufficiently large cohorts for studying genetic diseases has up to now been a needle in the haystack problem. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »